This is of clinical significance because, in tumors from glioblastoma multiforme patients, the expression of Yes and phosphorylation of SFKs, as well as an enhanced FasL expression, were observed in the zone of tumor–host interaction, suggesting their roles in glioma invasion [34]. Here, YES1 is linked to central nervous system cancer.